Pierfelice Tania Vanessa, Cinquini Chiara, Petrini Morena, D'Amico Emira, D'Arcangelo Camillo, Barone Antonio, Iezzi Giovanna
Department of Medical, Oral and Biotechnological Sciences, University "G. d'Annunzio", Via dei Vestini 31, 66013 Chieti, Italy.
Department of Surgical, Medical, Molecular Pathologies and of the Critical Area, University of Pisa, Lungarno Antonio Pacinotti, 43, 56126 Pisa, Italy.
Int J Mol Sci. 2025 Aug 6;26(15):7621. doi: 10.3390/ijms26157621.
A thermosensitive collagen-based gel (TSV gel), containing type I and III collagen, has been developed to improve the handling and stability of bone graft materials. However, its direct effect on osteoblasts is not well understood. This in vitro study evaluated the biological response of human oral osteoblasts to four bone substitutes: OsteoBiol GTO (larger granules with 20% TSV gel), Gen-OS (smaller granules), Gen-OS combined with 50% TSV gel (Gen-OS+TSV), and TSV gel alone. Cell proliferation, adhesion, morphology, collagen and calcium deposition, alkaline phosphatase (ALP) activity, gene expression of osteogenic markers and integrins, and changes in pH and extracellular calcium and phosphate levels were investigated. All materials supported osteoblast activity, but Gen-OS+TSV and GTO showed the most pronounced effects. These two groups promoted better cell adhesion and proliferation, higher ALP activity, and greater matrix mineralization. GTO improved cell adhesion, while the addition of TSV gel to Gen-OS enhanced biological responses compared with Gen-OS alone. Integrins α2, α5, β1, and β3, important for cell attachment to collagen, were notably upregulated in Gen-OS+TSV and GTO. Both groups also showed increased expression of osteogenic markers such as BMP-2, ALP, and osteocalcin (OCN). Higher extracellular ion concentrations and a more alkaline pH were observed, particularly in conditions without cells, suggesting active ion uptake by osteoblasts. In conclusion, combining TSV gel with collagen-based granules improves the cellular environment for osteoblast activity and may support bone regeneration more effectively than using either component alone.
一种含有I型和III型胶原蛋白的热敏性胶原基凝胶(TSV凝胶)已被开发出来,以改善骨移植材料的操作性和稳定性。然而,其对成骨细胞的直接作用尚不完全清楚。这项体外研究评估了人口腔成骨细胞对四种骨替代物的生物学反应:OsteoBiol GTO(含20%TSV凝胶的较大颗粒)、Gen-OS(较小颗粒)、Gen-OS与50%TSV凝胶混合(Gen-OS+TSV)以及单独的TSV凝胶。研究了细胞增殖、黏附、形态、胶原蛋白和钙沉积、碱性磷酸酶(ALP)活性、成骨标志物和整合素的基因表达,以及pH值、细胞外钙和磷水平的变化。所有材料均支持成骨细胞活性,但Gen-OS+TSV和GTO表现出最显著的效果。这两组促进了更好的细胞黏附和增殖、更高的ALP活性以及更大程度的基质矿化。GTO改善了细胞黏附,与单独的Gen-OS相比,向Gen-OS中添加TSV凝胶增强了生物学反应。对细胞附着于胶原蛋白很重要的整合素α2、α5、β1和β3在Gen-OS+TSV和GTO中显著上调。两组还显示出成骨标志物如骨形态发生蛋白-2(BMP-2)、ALP和骨钙素(OCN)的表达增加。观察到细胞外离子浓度更高且pH值更偏碱性,特别是在无细胞条件下,这表明成骨细胞有活跃的离子摄取。总之,将TSV凝胶与胶原基颗粒结合可改善成骨细胞活性的细胞环境,并且可能比单独使用任何一种成分更有效地支持骨再生。